Nilotinib-Associated Atherosclerosis Presenting as Multifocal Intracranial Stenosis and Acute Stroke
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Neurology (clinical),Rehabilitation,Surgery
Reference13 articles.
1. Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML;Aichberger;Am J Hematol,2011
2. Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?;Valent;Eur J Clin Investig,2010
3. Tyrosine kinase inhibitor–associated cardiovascular toxicity in chronic myeloid leukemia;Moslehi;J Clin Oncol,2015
4. Cerebrovascular events during nilotinib treatment;Jager;Netherl J Med,2014
5. Nilotinib as a risk factor for ischemic stroke: a series of three cases;Gomez-Galvan;Neurologia,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacotherapy and cardiovascular challenges: a case report of olverembatinib-induced myocardial infarction with non-obstructive coronary arteries;BMC Cardiovascular Disorders;2024-07-02
2. The evaluation value of intracranial magnetic resonance angiography combined with carotid ultrasound in cerebral infarction;Pakistan Journal of Medical Sciences;2024-05-21
3. Case report: Three characteristics of tyrosine kinase inhibitor-associated cerebrovascular stenosis. High threshold for infarction, atypical infarct area, and vascular recoverability under the use of ponatinib;Frontiers in Stroke;2024-04-03
4. Tyrosine Kinase Inhibitor-induced Cerebrovascular Occlusion Presenting with Moyamoya Disease-like Stenosis of the Circle of Willis;Internal Medicine;2024
5. Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia;Internal Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3